Skip to main content

. 1997 Mar;62(3):302–303. doi: 10.1136/jnnp.62.3.302-a

Low dose interferon-alpha is safe in patients with myasthenia gravis.

H Bolay, R Karabudak, K Varli, O Saribas

PMCID: PMC1064180 PMID: 9069506

302

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Batocchi A. P., Evoli A., Servidei S., Palmisani M. T., Apollo F., Tonali P. Myasthenia gravis during interferon alfa therapy. Neurology. 1995 Feb;45(2):382–383. doi: 10.1212/wnl.45.2.382. [DOI] [PubMed] [Google Scholar]
Piccolo G., Franciotta D., Versino M., Alfonsi E., Lombardi M., Poma G. Myasthenia gravis in a patient with chronic active hepatitis C during interferon-alpha treatment. J Neurol Neurosurg Psychiatry. 1996 Mar;60(3):348–348. doi: 10.1136/jnnp.60.3.348. [DOI] [PMC free article] [PubMed] [Google Scholar]
Rönnblom L. E., Alm G. V., Oberg K. E. Autoimmunity after alpha-interferon therapy for malignant carcinoid tumors. Ann Intern Med. 1991 Aug 1;115(3):178–183. doi: 10.7326/0003-4819-115-3-178. [DOI] [PubMed] [Google Scholar]
Shenoy M., Baron S., Wu B., Goluszko E., Christadoss P. IFN-alpha treatment suppresses the development of experimental autoimmune myasthenia gravis. J Immunol. 1995 Jun 1;154(11):6203–6208. [PubMed] [Google Scholar]

ACTIONS

RESOURCES